P neumocystis jirovecii infection (PJP) is a common cause of pneumonia in patients with
cancer‐related immunosuppression. There are well‐defined patients who are at risk of PJP …

There is an increasing use of monoclonal antibodies in the treatment of haematological
malignancies. Alemtuzumab (Campath‐1H; Ilex Pharmaceuticals, San Antonio, TX, USA) is …

Obesity causes a number of changes, including an increase in volume of distribution and
changes in hepatic metabolism and renal excretion. Several antibiotics have sufficient data …

Introduction A pandemic coronavirus, SARS‐CoV‐2, causes COVID‐19, a potentially life‐
threatening respiratory disease. Patients with cancer may have compromised immunity due …

Background Candidaemia in cancer patients is associated with increasing fluconazole
resistance. Models for predicting such isolates and their clinical impact are required …

Objectives With increasing global interest in hospital antimicrobial stewardship (AMS)
programmes, there is a strong demand for core elements of AMS to be clearly defined on the …

Stenotrophomonas maltophilia is a ubiquitous organism associated with opportunistic
infections. In the immunocompromised host, increasing prevalence and severity of illness is …

Invasive aspergillosis (IA) in haematology/oncology patients presents as primary infection or
breakthrough infection, which can become refractory to antifungal treatment and has a high …

Background Penicillin allergies are associated with inferior patient and antimicrobial
stewardship outcomes. We implemented a whole-of-hospital program to assess the efficacy …

Background Despite the high prevalence of patient-reported antibiotic allergy (so-called
antibiotic allergy labels [AALs]) and their impact on antibiotic prescribing, incorporation of …